Navigation Links
Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
Date:4/21/2008

- 2008 Outlook Reaffirmed -

MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2008, income from continuing operations was $141 million, or $0.72 per diluted share, compared to $108 million, or $0.55 per diluted share, in the first quarter of 2007. Included in the results for the first quarter of 2007 were special charges of $0.04 per diluted share principally associated with workforce reductions.

First quarter revenues were $1.8 billion, an increase of 16.9% compared to the prior-year level. The inclusion of AmeriPath, which the company acquired on May 31, 2007, increased consolidated revenues by 13%. Clinical testing revenues increased by 17.1% compared to the prior year. Revenue per requisition increased 10.8% and clinical testing volume, measured by the number of requisitions, increased 5.6%. The acquisition of AmeriPath increased revenue per requisition by 7.8% and clinical testing volume by 5.8%.

"Quest Diagnostics generated strong growth in the first quarter, with a 17% increase in revenues and a 31% increase in earnings per share," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer. "We are making good progress executing our plans; driving profitable revenue growth; continuing to reduce our cost structure and improve efficiency; and further aligning our AmeriPath business with Quest Diagnostics."

Dr. Mohapatra continued: "We also produced double-digit revenue growth in our near-patient, or point-of-care, testing business and opened our lab in India. We completed the first quarter firmly on track
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
3. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
4. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
5. New conference tackles the tough questions in lung cancer
6. The Quest for Americas Life in Beautiful Smiles: Captured in Photography
7. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
8. Study questions cost of complexity in evolution
9. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
10. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
11. Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...OMX Copenhagen: “EXQ”) announced today...eening Facility (ICCB-L) has been recognized as a ...upports investigators at Harvard Medical School, a...-throughput screening of small molecule and RNAi l...d Copenhagen, Denmark (PRWEB) November 30, 2009 --...
(Date:11/30/2009)...ING, Pa., Nov. 30 The University H...it has signed an agreement with ECRI Institute...medical center members special pricing on ECRI,s l...ent will offer UHC members current data to assist ...t nonprofit organization, is a leader in providing...
(Date:11/30/2009)...ewswire/ -- Raleigh dentist Robert L. Williamson...to educate the community and patients about sedati...a series of free educational videos and online inf...educating the public about the benefits of sedati...al care educational videos are available free onli...
(Date:11/30/2009)...d that beverage can pull-tabs were being swallowed...rers to stay-tabs. But a study presented today at ...North America (RSNA) found that the new tabs are s...actors leading the change in beverage can construc...lowing of the pull-tab and potential related injur...
(Date:11/30/2009)...enient technique that, when added to breast ultras...rom benign results, according to an ongoing study ...logical Society of North America (RSNA). , When ... often use ultrasound to obtain additional informa...ult in more biopsies because of its relatively low...
Breaking Medicine News(10 mins):Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 4Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3Health News:Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry 2Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Elastography reduces unnecessary breast biopsies 2
...on,t prove cause and effect , , THURSDAY,... enough of the antioxidant vitamins A and C in the...sh researchers say. , The pooled results of 40 stu...se. The average intake among those with asthma was...
...rence Track will Offer Attendees the Latest Resour...el Brands , , NEW YORK, April 16 With consumers ...A audience looking for private label and contract ... 15-17, 2009 at the Jacob K. Javits Convention Cen...
... Ports Calls on Members of Congress to Protect Por...e Safety & Security , , LOS ANGELES and WASHI...clean the air and create good green jobs at our na...denial of the Federal Maritime Commission,s (FMC) ...
...may be applicable to other pathogens , , T...lled SopB enables salmonella bacteria to invade ce...nctions to avoid destruction, Yale University rese...utionary terms, this hijacking of cellular machine...
...Adapts to Dieter,s Lifestyle , , OWINGS MILLS, Md...nnounced the grand opening of its newest Medifast ...ast Weight Control Center is located at The Shops ...9 a.m.-3 p.m. For more information and to find the...
...rsity research team has found that a painful pelvi...requently in adolescent boys. Chronic prostatitis ...genital disease associated with persistent and lif...gative impact that pain, urinary symptoms, and dep...
Other Medicine News:Health News:Low Vitamin A, C Intake Tied to Asthma Risk 2Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 2Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 3Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 2Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 3Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 4Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 5Health News:Medifast Weight Control Center Opens in Austin, TX 2Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2
(Date:11/29/2009)... Stimulated by the ten years of Sy...dical Systems USA announced today, at the Radiolog...g, the formation of its Medical Informatics Divis...w group will integrate all functions associated wi...a platform for future growth. ,, Several organi...
(Date:11/27/2009)...tion to prevent illnesses caused by subtypes A and.... 27 The U.S. Food and ...ple ages 18 years and older to prevent disease cau...Logo: http://www.newscom.com/cgi-bin/prnh/2009082...s Vaccines and Diagnostics in Siena, Italy, was ap...
(Date:11/26/2009)..., South Africa, Nov. 26 The 2009 F...ar Award in the Generic Pharmaceutical Market is p..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...ward, the following criteria were used to benchmar...rs: growth strategy and implementation, degree of ...
Breaking Medicine Technology:FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3FDA Approves Agriflu Seasonal Influenza Vaccine 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4New national adolescent weight control registry will recognize successful teen weight loss efforts 50961 1New national adolescent weight control registry will recognize successful teen weight loss efforts 50961 2New monkey discovered in Brazil 9148 1New monkey discovered in Brazil 9148 2Sustainable bioenergy project has global launch 9145 1Sustainable bioenergy project has global launch 9145 2
...eceived Regulatory Approval for Three Phase II Can...with Chemotherapy --, -- New Clinical Trial Will E... Combination with Carboplatin and Paclitaxe...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...ibodies for the treatment of cancer and,hepatitis ...
...22 EpiCept Corporation,(Nasdaq and OMX Nordic Exc...ory and clinical status of Ceplene(TM) (histamine ...go: http://www.newscom.com/cgi-bin/prnh/20020513/...arketing Authorization Application,(MAA) seeking m...n has,advanced to the next important step. The Com...
Other Medicine Technology:Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 4EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream 2EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream 3EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream 4
Torso Brief V-85
Female High Waist Brief, Side Closure
Arm Support Sleeves
Short-Sleeve Bolero
Medicine Products: